EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
By LabMedica International staff writers Posted on 01 Aug 2018 |

Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK), a global in vitro diagnostics company, highlighted its new Stanbio Chemistry Glycated Albumin (GA) assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care (POC) analyzer at the AACC 2018 Clinical Lab Expo held in Chicago, Illinois, from July 29 to August 2. AACC is the world’s largest exposition for clinical laboratory products and services.
EKF Diagnostics manufactures POC and central laboratory technology, including tests for hemoglobin, HbA1c, glucose, lactate and a range of chemistry reagents. The company’s POC blood analyzers aid the diagnosis of anemia, diabetes and associated conditions, and its products are used by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, sports medicine, emergency rooms and laboratories.
At AACC 2018, EKF highlighted the Stanbio GA assay, which has FDA 510(k) clearance for sale in the US. The Stanbio Chemistry GA assay uses an enzymatic method with liquid reagents and does not require preparation. It can be used on compatible open channel clinical chemistry analyzers and expresses results as a ratio of GA to Albumin in mmol/mol from a small amount of blood serum.
EKF also demonstrated the use of its newly FDA 510(k) cleared and CLIA waived DiaSpect Tm hemoglobin analyzer at this year’s AACC. DiaSpect Tm analyzes whole blood from a sampling microcuvette designed to collect a blood sample from any angle without forming air bubbles, thus minimizing the need to repeat the testing procedure. DiaSpect Tm delivers lab quality hemoglobin results in about one second of the microcuvette being placed in the analyzer, making it the world’s fastest hemoglobin analyzer and ideal for efficient patient health checks and anemia screening at the POC. The hand-held and reagent free system is suitable and cleared for use in POC and Certificate of Waiver settings, including physician’s offices, clinics and other non-traditional laboratory locations.
EKF Diagnostics manufactures POC and central laboratory technology, including tests for hemoglobin, HbA1c, glucose, lactate and a range of chemistry reagents. The company’s POC blood analyzers aid the diagnosis of anemia, diabetes and associated conditions, and its products are used by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, sports medicine, emergency rooms and laboratories.
At AACC 2018, EKF highlighted the Stanbio GA assay, which has FDA 510(k) clearance for sale in the US. The Stanbio Chemistry GA assay uses an enzymatic method with liquid reagents and does not require preparation. It can be used on compatible open channel clinical chemistry analyzers and expresses results as a ratio of GA to Albumin in mmol/mol from a small amount of blood serum.
EKF also demonstrated the use of its newly FDA 510(k) cleared and CLIA waived DiaSpect Tm hemoglobin analyzer at this year’s AACC. DiaSpect Tm analyzes whole blood from a sampling microcuvette designed to collect a blood sample from any angle without forming air bubbles, thus minimizing the need to repeat the testing procedure. DiaSpect Tm delivers lab quality hemoglobin results in about one second of the microcuvette being placed in the analyzer, making it the world’s fastest hemoglobin analyzer and ideal for efficient patient health checks and anemia screening at the POC. The hand-held and reagent free system is suitable and cleared for use in POC and Certificate of Waiver settings, including physician’s offices, clinics and other non-traditional laboratory locations.
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
- Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more